March 22, 2024
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)
This Notice is to inform potential applicants of changes to the language and page limitations regarding allowable appendices. The following changes are made to Notice of Funding Opportunity (NOFO) PAR-24-105 "Limited Competition: Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed)", effective immediately, and applicable for the May 1, 2024 and September 1, 2024 application due dates.
The following section of PAR-24-105 has been modified:
Currently Reads:
2. Content and Form of Application Submission
Overall Component
Other Plan(s):
Appendix:
Only limited items are allowed in the Appendix. Follow all instructions for the Appendix as described in How to Apply- Application Guide ; any instructions provided here are in addition to the Application Guide instructions.
Resource Component
Other Plan(s):
Appendix:
Only limited items are allowed in the Appendix. Follow all instructions for the Appendix as described in How to Apply- Application Guide ; any instructions provided here are in addition to the Application Guide instructions.
Modified to Read (changes shown in bold italics):
2. Content and Form of Application Submission
Overall Component
Other Plan(s):
Appendix:
Only limited items are allowed in the Appendix. Follow all instructions for the Appendix as described in How to Apply- Application Guide; any instructions provided here are in addition to the Application Guide instructions. The following are allowable Appendix materials for the Overall Component (30 pages maximum):
Resource Component
Other Plan(s):
Appendix:
Only limited items are allowed in the Appendix. Follow all instructions for the Appendix as described in How to Apply- Application Guide; any instructions provided here are in addition to the Application Guide instructions. The following are allowable Appendix materials for the Overall Component (30 pages maximum):
All other aspects of this NOFO remain the same.
Please direct all inquiries to:
Oleg Mirochnitchenko, Ph.D.
Phone: 301-435-0748
Email: [email protected]